Cardiology Division, Ospedale Cardinal Massaia, Asti, Italy.
Europace. 2010 May;12(5):702-7. doi: 10.1093/europace/euq045. Epub 2010 Feb 25.
Monitoring of haemodynamic parameters or surrogate parameters of the left ventricle is especially important for patients under cardiac resynchronization therapy (CRT). Intracardiac impedance reflects left ventricular (LV) volume changes well in animal models. Since it is unknown whether this also holds in humans with heart failure (HF), we examined the correlation of LV intracardiac impedance with haemodynamic parameters in CRT patients for different positions of the LV lead.
In 14 HF patients with non-ischaemic cardiomyopathy (four female, age 70 +/- 6 years, NYHA 2.9 +/- 0.3, EF 26 +/- 6%), one or two suitable implantation sites for the LV lead were selected. Following atrial, right ventricular, and LV catheter positioning, a micro-manometer catheter was placed in the ascending aorta. Surface ECG, impedance, and aortic pressure were recorded during graded overdrive bi-ventricular pacing in DDD mode. The correlation between impedance and stroke volume (SV) or pulse pressure (PP) changes was compared for different LV lead positions. In total, 20 overdrive pacing tests were performed at six different LV lead positions. Strong correlations were found between stroke impedance (SZ) and SV (R = 0.82 +/- 0.16) as well as between SZ and PP (R = 0.81 +/- 0.16) without significant influence of LV lead position.
In HF patients, a strong correlation between changes in intracardiac impedance and LV SV was found. Typical LV lead implant positions have been tested and all appear to be suitable for this method of LV volume monitoring.
心脏再同步治疗(CRT)患者尤其需要监测血流动力学参数或左心室(LV)的替代参数。心内阻抗在动物模型中能很好地反映 LV 容积变化。由于尚不清楚心力衰竭(HF)患者是否也是如此,我们研究了 CRT 患者不同 LV 导联位置时 LV 心内阻抗与血流动力学参数的相关性。
在 14 名非缺血性心肌病(女性 4 名,年龄 70 +/- 6 岁,NYHA 2.9 +/- 0.3,EF 26 +/- 6%)的 HF 患者中,选择了一个或两个合适的 LV 导联植入部位。在心房、右心室和 LV 导管定位后,将微测压导管放置在升主动脉中。在 DDD 模式下进行分级超速双心室起搏时,记录体表心电图、阻抗和主动脉压。比较了不同 LV 导联位置时阻抗与心搏量(SV)或脉压(PP)变化之间的相关性。总共在六个不同的 LV 导联位置进行了 20 次超速起搏测试。在 LV 导联位置无明显影响的情况下,阻抗与 SV(R = 0.82 +/- 0.16)之间以及阻抗与 PP(R = 0.81 +/- 0.16)之间均存在较强相关性。
在 HF 患者中,心内阻抗变化与 LV SV 之间存在很强的相关性。已经测试了典型的 LV 导联植入位置,并且似乎所有位置都适合这种 LV 容积监测方法。